Kidney Disease Biomarkers Improve Heart Failure Risk Prediction in the General Population
Circulation: Heart Failure, <a href=”https://www.ahajournals.org/toc/circheartfailure/13/8″>Volume 13, Issue 8</a>, August 1, 2020. Source link
Read moreHybrid Training in Acute Cardiovascular Care
Saraschandra Vallabhajosyula Saraschandra Vallabhajosyula, MD, MSc, Department of Cardiovascular Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905. Email
Read moreLower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure
What Is New? The Post-Approval Study of 1200 patients in multiple practice settings demonstrated a 57% reduction in risk of
Read moreTranscatheter Aortic Valve Replacement in Low-Population Density Areas
Circulation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/13/8″>Volume 13, Issue 8</a>, August 1, 2020. Source link
Read moreCorrection to: Aptamer-Based Proteomic Platform Identifies Novel Protein Predictors of Incident Heart Failure and Echocardiographic Traits
© American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is qualified 501(c)(3) tax-exempt organization.*Red
Read moreResponse by Bonde and Martinussen to Letter Regarding Article, “Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort”
“Response by Bonde and Martinussen to Letter Regarding Article, “Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental
Read moreUnderstanding the Complexity of Heart Failure Risk and Treatment in Black Patients
Compared with other race/ethnic groups, Black patients have the highest incidence and prevalence of heart failure (HF) as well as
Read moreLetter by Nielsen and Søgaard Regarding Article, “Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort”
Mette Søgaard https://orcid.org/0000-0002-2830-4968 Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Faculty of Health, Aalborg University, Denmark (P.B.N., M.S.). Department
Read moreDoes the Choice Between a Telehealth and an In-Person Appointment Change Patient Attendance?
Telemedicine and e-Health, Ahead of Print. Source link
Read moreMobile Device Usage by Gender Among High-Risk HIV Individuals in a Rural, Resource-Limited Setting
Background:Mobile health (mHealth) is a promising tool to deliver healthcare interventions to underserved populations. We characterized the use of mobile
Read more